October 2011: FDC receives prestigious Pharmexcil Patents National Award 2010-11 in the recognition of FDC's contribution to R&D in bulk drug category. FDC's Ophthalmic unit at Waluj receives UKMHRA approval (April 2011). FDC receives approval from UKMHRA (RMS) for Dorzolamide 2% w/v Eye Drop Solution and Dorzolamide 2% w/v & Timolol Maleate 0.5% w/v Eye Drop Solution under Decentralised Procedure (June 2011)
F reedom of choice- Wide spectrum of Therapeutic segments to choose from.
D edication to serve- Highest quality standards with latest technology at affordable prices.
C are for all- Always committed towards better healthcare solutions.

Welcome

to the world of FDC
FDC Eyrdrop
FDC International